AAP Issues Updated Guidance on Palivizumab Use for the 2022-2023 RSV Season
The American Academy of Pediatrics (AAP) has published updated guidance on the use of palivizumab prophylaxis to prevent hospitalization from…
AAP Issues Updated Guidance on Palivizumab Use for the 2022-2023 RSV Season
Home » Specialties » Pediatrics The American Academy of Pediatrics (AAP) has published updated guidance on the use of palivizumab…
AAP Issues Updated Guidance on Palivizumab Use for the 2022-2023 RSV Season
Home » Specialties » Womens Health The American Academy of Pediatrics (AAP) has published updated guidance on the use of…
Patients, Clinicians Explain How the Pandemic Affected Genitourinary Cancer Care
A focus group of supportive care health professionals and consumers discussed concerns about how the pandemic has changed care of…
Chronic Kidney Disease
COVID19
Diabetes
Diabetic Nephropathy
Infectious Disease
Medications
Medicine
Respiratory Diseases/Disorders
US
Finerenone May Protect Against Pneumonia and COVID-19
Finerenone may prevent pneumonia and COVID-19 in patients with chronic kidney disease (CKD) and type 2 diabetes, according to a…
FDA Authorizes Use of Novavax COVID-19 Vaccine, Adjuvanted in Adolescents
The Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for Novavax COVID-19 Vaccine, Adjuvanted to include…
Novavax Submits EUA Request for COVID-19 Vaccine Booster
An Emergency Use Authorization (EUA) request has been submitted to the US Food and Drug Administration (FDA) for the adjuvanted…
Novavax Submits EUA Request for COVID-19 Vaccine Booster
An Emergency Use Authorization (EUA) request has been submitted to the Food and Drug Administration (FDA) for the Novavax COVID-19…
Back to School: Time For COVID-19 Vaccinations
It’s back-to-school time in much of the United States. In addition to purchasing school supplies, parents are also scheduling physicals,…
In the COVID-19 Era, Are In-Person Conferences Worth the Risks?
In-person medical conferences are back in full swing this year, and members of the oncology community are weighing the risks…